In September 2014 BMC conducted a detailed market and technology analysis (a kind of an “IN DEPTH” type of analysis) for a one of the OncoArendi Therapeutics’ technologies. Results of the work constituted a basis for the market part of the STRATEGMED application in the National Research and Development competition. The application was positively evaluated… Read more »